Biodexa Pharmaceuticals (BDRX) is making progress in readying the launch of a phase 3 trial for eRapa, its proprietary encapsulated form of ...

A team at Baylor College of Medicine conducted research to identify novel cell-surface cancer/germline antigens (CGAs) expressed in triple-negative breast cancer (TNBC) that could serve as targets for ...

Researchers at the Icahn School of Medicine at Mount Sinai, led by Nina Bhardwaj, MD, Ph.D., Ward-Coleman Chair in Cancer ...

SESAUA annual meeting featured a kidney cancer session and a presentation by Dr. Robert Smith discussing how age and tumor ...

Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...

Dr. Chandler Park sat down for an interview with CURE® to discuss the biggest takeaway from the 2025 ASCO GU Symposium in ...

Kidney cancer incidences are rising among people under 50, linked to factors like obesity, hypertension, and smoking. This ...

In a study published online March 10 in Cancer, authors identified gliomas with mutational signatures associated with ...

When a gene gets duplicated, it often leads to the recipe being followed too many times, and the resulting “leftovers,” the ...

Genetic testing, via germline and somatic testing, is crucial in breast cancer to understand inherited risks and tumor ...

A study of 666 localised prostate tumours identified 223 driver regions, many influenced by structural variations ...

A study conducted by researchers at the University of Tartu showed a nearly five-fold enrichment of hereditary cancer ...